Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Chickenpox"
Show Display Options
Rank Status Study
1 Not yet recruiting Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Condition: Persistence of Varicella Immunity
Intervention: Biological: Varicella vaccine
2 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
3 Recruiting Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Conditions: Liver Disease;   Immunosuppression;   Varicella
Intervention: Biological: Vaccination with VZV vaccine
4 Not yet recruiting Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine in Children With Liver Disease
Conditions: Varicella;   Transplants
Intervention: Biological: varicella vaccine
5 Recruiting Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
Condition: Psoriasis
Interventions: Drug: Varicella Zoster Vaccine;   Drug: Placebo
6 Recruiting Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination
Condition: Pregnancy
Intervention: Biological: Serological Test s for the Virus Chicken Pox Virus
7 Recruiting Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
Conditions: Materno-fetal Transfer of Anti-HCMV-IgG;   Materno-fetal Transfer of Anti-VZV-IgG
Intervention: Other: Blood samples
8 Recruiting Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
Conditions: RENAL INSUFFICIENCY, CHRONIC;   LIVER FAILURE, ACUTE;   HEART DISEASE
Intervention: Biological: ProQuad
9 Recruiting iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS
Condition: Sarcomas
Interventions: Genetic: GD2 T cells;   Biological: VZV vaccine

Study has passed its completion date and status has not been verified in more than two years.